That did cross my mind as well Funkeeh, being in a Ph3 but funded until Interim analysis by the FDA (being Orphan Disease, it is possible to gain priority review for Approval to market) & Unlisted option conversion for the rest of the trial funding.
DXB are quite regularly updating their Investor Presentation & getting the word out which is helpful to all of us, not just new investors.
I guess the DMX-700 pre-clinical results in COPD are very compelling though & hence I am keeping an open mind on moving forward with that IP ASAP.
Being also invested in IMU, who already had $100 mill in the bank & just raised another $80 million (a bit of a surprise to SH), it’s wise to never assume, especially when there are multiple irons in the fire with IP & we are still waiting on 2 external COVID-19 trial results here on DXB.
If they are positive results, well who knows? REMAP-CAP may extend DMX-200 plus ARB in trials, like they have with convalescent plasma in subgroups. New data on COVID coming out.
Recent data published by REMAP-CAP team:
https://link.springer.com/content/pdf/10.1007/s00134-022-06869-w.pdf
A lot of high risk patients for severe COVID (older, co-morbidity ie DKD, CKD, CVD) may already be on ARB, ACEi so would have excluded them (exclusion criteria) from recruitment onto the RAS Domain in REMAP-CAP & also I believe CLARITY trials, but not other Domains of REMAP-CAP.
Anyway, I also hope to hear some news soon, because if an oral treatment is beneficial, it could save a lot of heartbreak & a lot of health dollars being a global issue.
Anti-virals help, but not everyone tests positive quickly. I have had COVID-19 twice now, and obviously different “flavours” of the virus & 4 times positive cases in our household.
Symptoms were different between infections. & negative on RAT & PCR until day 5 or 6 of symptoms, so out of that window period for anti-virals anyway, & from what I’m hearing this isn’t uncommon, especially in vaccinated people. (Please not let’s go there again, it’s personal choice or mandatory for work & new strains are vaccine evasive for becoming infected, just may not get so sick & end up in hospital) so will be getting booster shots & just deal with it at the time. Twice being infected with COVID in 4 months is enough to deal with & I don’t want it again.
GLTAH
- Forums
- ASX - By Stock
- DXB
- Ann: Investor Presentation
Ann: Investor Presentation, page-20
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
41.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $228.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3087 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 2222 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3087 | 0.425 |
5 | 58665 | 0.415 |
4 | 37701 | 0.410 |
1 | 100000 | 0.405 |
5 | 157500 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 2222 | 1 |
0.390 | 20000 | 1 |
0.400 | 14054 | 2 |
0.410 | 16015 | 4 |
0.415 | 209389 | 3 |
Last trade - 09.57am 10/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
Day chart unavailable
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online